FGF21 and obesity due to melanocortin 4 receptor deficiency: In view of the important role of FGF21 in obesity, the pharmaceutical industry has developed FGF21 analogs or FGF21 receptor agonists to overcome the shortcomings of the natural FGF21 protein, and these treatments have entered the clinical stage.